In contrast, it is reported that RIPK1 and RIPK3 are overexpressed in pancreatic cancer tissues, and downregulation of RIPK1 or deletion of RIPK3 in vivo inhibited tumor progression via enhancing immune cell infiltration [9]. This evidence concerns the gene RIPK1 and familial pancreatic carcinoma.